Skip to content

Preclinical models of antipsychotic drug action

José L. Moreno, Javier González-Maeso

The International Journal of Neuropsychopharmacology June 10, 2013 DOI: 10.1017/s1461145713000606 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics LSD Psilocybin Serotonin
Keywords Phencyclidine Dissociative Hallucinogen Schizophrenia object-oriented programming Pharmacology Metabotropic glutamate receptor Metabotropic receptor Antipsychotic Drug Psychosis Mechanism of action Nmda receptor
Citations 30
Key findings Serotonin 5-HT2A and metabotropic glutamate 2 receptors are implicated in the neurobiology of schizophrenia and its treatment, based on rodent models using LSD-like and PCP-like drugs.

Abstract

Abstract One of the main obstacles faced by translational neuroscience is the development of animal models of psychiatric disorders. Behavioural pharmacology studies indicate that psychedelic drugs, such as lysergic acid diethylamide (LSD) and dissociative drugs, such as phencyclidine (PCP), induce in healthy human volunteers psychotic and cognitive symptoms that resemble some of those observed in schizophrenia patients. Serotonin 5-HT2A and metabotropic glutamate 2 receptors have been involved in the mechanism of action of psychedelic and dissociative drugs. Here we review recent advances using LSD-like and PCP-like drugs in rodent models that implicate these receptors in the neurobiology of schizophrenia and its treatment.

Comparable studies

Other narrative reviews on LSD, most cited first.

Citations in the library

Explore topics